The total amount of venture capital investing in genomics firms rose to $392 million in 2012, up from $332 million in 2011, according to the blog Seqonomics.

The amount is the most in VC funding to genomics firms that Seqonomics has found, going back to 2006. However, rather than there being more VC deals in 2012, Sanger Institute postdoctoral fellow Art Wuster says that the higher amount in total investments results from a higher average for each investment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Moving Money Around

The Cost Burden

R&D Dollars

That Tiny Little Bit?

In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.

GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.

Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.

A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.